top of page
News, Events and Updates
Search
Anavex Appoints Dr. Rachelle Doody to Scientific Advisory Board
Feb 23, 2011
Anavex Adds Dr. Paul Aisen to Scientific Advisory Board
Feb 16, 2011
Anavex Comments on President Obama’s Signing of National Alzheimer’s Project Act into Law
Jan 18, 2011
Alzheimer’s Weekly Names ANAVEX 2-73 the Number One Most Promising Trial Drug in Alzheimer’s Disease
Jan 6, 2011
Anavex Files Phase I Regulatory Submission for ANAVEX 2-73 in Alzheimer’s Disease
Dec 21, 2010
Anavex Appoints David Tousley as CFO
Sep 30, 2010
ANAVEX 2-73: Journal of Psychopharmacology Publishes Anti-Amnesic and Neuroprotective Data
Sep 13, 2010
Neuroprotective efficacy of ANAVEX 2-73, a novel tetrahydrofuran derivative targeting the sigma-1...
Sep 11, 2010
Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/σ1 ligand ANAVEX 2-73
Sep 9, 2010
Anavex to Present at Rodman & Renshaw Healthcare Conference September 13 in New York City
Sep 8, 2010
Dr. Cameron Durrant Named One of PharmaVOICE’s 100 Most Inspiring in the Pharmaceutical Industry
Aug 30, 2010
45
46
47
48
49
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
